Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma

1 意见
administrator
administrator
08/09/23

Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个